Double <i>EGFR</i> mutants containing rare <i>EGFR</i> mutant types show reduced <i>in vitro</i> response to gefitinib compared with common activating missense mutations

Issan Yee San Tam(University of Hong Kong), Maria P. Wong(Queen Mary Hospital)
Molecular Cancer Therapeutics
August 1, 2009
Cited by 79


Related Papers

No related papers found

Powered by citation graph analysis